Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties
William Montgomery1, Tamas Treuer2, Jamie Karagianis3, Haya Ascher-Svanum4, Gavan Harrison51Global Health Outcomes, Eli Lilly and Company, Sydney, Australia; 2Emerging Markets Business Unit (Neuroscience), Eli Lilly and Company, Budapest, Hungary; 3Eli Lilly and Company, Indianapolis, IN, USA; 4Glob...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-02-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/orally-disintegrating-olanzapine-review-effectiveness-patient-preferen-a9188 |